AU403: Novel selective LXRβ-PPAR selective agonist for Alzheimer’s Disease

AU403 helps mitigate ADRD, including APOe4 patients, develop neurodegeneration due to dysregulation of neuro-metabolism and neuro- cholesterol that induces aggregation of proteins, neuroinflammation and pathological hallmarks that lead to neurodegeneration.

Amin_lab_Auburn_BioALABAMA_2022

.pdf

Download PDF • 1.07MB